Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome

<p><b>Aim:</b> Blood levels of 25-hydroxyvitamin D [25(OH) D] are reduced in patients with nephrotic syndrome (NS). The lowering is thought to be due to urinary loss of vitamin D binding protein (DBP). A link between vitamin D deficiency and bone disease or markers of mineral meta...

Full description

Bibliographic Details
Main Authors: Aggarwal, A, Yadav, A, Ramachandran, R, Kumar, V, Sachdeva, N, Khandelwal, N, Jha, V
Format: Journal article
Language:English
Published: Wiley 2016
_version_ 1797087347510083584
author Aggarwal, A
Yadav, A
Ramachandran, R
Kumar, V
Kumar, V
Sachdeva, N
Khandelwal, N
Jha, V
author_facet Aggarwal, A
Yadav, A
Ramachandran, R
Kumar, V
Kumar, V
Sachdeva, N
Khandelwal, N
Jha, V
author_sort Aggarwal, A
collection OXFORD
description <p><b>Aim:</b> Blood levels of 25-hydroxyvitamin D [25(OH) D] are reduced in patients with nephrotic syndrome (NS). The lowering is thought to be due to urinary loss of vitamin D binding protein (DBP). A link between vitamin D deficiency and bone disease or markers of mineral metabolism has not yet been shown in NS. We hypothesized that alterations in bioavailable vitamin D levels might be linked to these abnormalities in NS. </p><p><b>Methods:</b> We measured circulating levels of 25(OH)D, 1,25-dihydroxyvitamin D [1,25(OH)<sub>2</sub>D], DBP, serum albumin and intact parathyroid hormone (iPTH) in 106 adults with sporadic idiopathic NS and 40 healthy controls. Bioavailable vitamin D was calculated from previously validated formulae. Bone mineral density (BMD) was measured at left hip (neck of femur) by DEXA. </p><p><b>Results:</b> Compared to healthy controls, total and bioavailable 25(OH)D levels were significantly reduced in patients with NS as compared to healthy controls. Among the nephrotic patients, BMD was positively correlated with bioavailable 25(OH)D (r = 0.358; <i>P</i> = 0.0002) but not with total 25(OH)D (r = 0.174; <i>P</i> = 0.079). Total 1,25(OH)<sub>2</sub>D and bioavailable 1,25(OH)<sub>2</sub>D did not correlate with BMD (r = 0.131; <i>P</i> = 0.206 and r = 0.107, <i>P</i> = 0.295). Bioavailable 25(OH)D levels showed a strong inverse correlation with iPTH on univariate (r = −0.457; <i>P</i> &lt; 0.0001) and multivariate (β=−0.453, <i>P</i> &lt; 0.0001) analyses. </p><p><b>Conclusions:</b> We conclude that bioavailable 25(OH)D is a better measure of vitamin D status with respect of BMD and mineral metabolism in patients of nephrotic syndrome.</p>
first_indexed 2024-03-07T02:34:28Z
format Journal article
id oxford-uuid:a8538bc5-4fe3-429d-8c9a-25c43d49ec74
institution University of Oxford
language English
last_indexed 2024-03-07T02:34:28Z
publishDate 2016
publisher Wiley
record_format dspace
spelling oxford-uuid:a8538bc5-4fe3-429d-8c9a-25c43d49ec742022-03-27T03:00:39ZBioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndromeJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a8538bc5-4fe3-429d-8c9a-25c43d49ec74EnglishSymplectic Elements at OxfordWiley2016Aggarwal, AYadav, ARamachandran, RKumar, VKumar, VSachdeva, NKhandelwal, NJha, V <p><b>Aim:</b> Blood levels of 25-hydroxyvitamin D [25(OH) D] are reduced in patients with nephrotic syndrome (NS). The lowering is thought to be due to urinary loss of vitamin D binding protein (DBP). A link between vitamin D deficiency and bone disease or markers of mineral metabolism has not yet been shown in NS. We hypothesized that alterations in bioavailable vitamin D levels might be linked to these abnormalities in NS. </p><p><b>Methods:</b> We measured circulating levels of 25(OH)D, 1,25-dihydroxyvitamin D [1,25(OH)<sub>2</sub>D], DBP, serum albumin and intact parathyroid hormone (iPTH) in 106 adults with sporadic idiopathic NS and 40 healthy controls. Bioavailable vitamin D was calculated from previously validated formulae. Bone mineral density (BMD) was measured at left hip (neck of femur) by DEXA. </p><p><b>Results:</b> Compared to healthy controls, total and bioavailable 25(OH)D levels were significantly reduced in patients with NS as compared to healthy controls. Among the nephrotic patients, BMD was positively correlated with bioavailable 25(OH)D (r = 0.358; <i>P</i> = 0.0002) but not with total 25(OH)D (r = 0.174; <i>P</i> = 0.079). Total 1,25(OH)<sub>2</sub>D and bioavailable 1,25(OH)<sub>2</sub>D did not correlate with BMD (r = 0.131; <i>P</i> = 0.206 and r = 0.107, <i>P</i> = 0.295). Bioavailable 25(OH)D levels showed a strong inverse correlation with iPTH on univariate (r = −0.457; <i>P</i> &lt; 0.0001) and multivariate (β=−0.453, <i>P</i> &lt; 0.0001) analyses. </p><p><b>Conclusions:</b> We conclude that bioavailable 25(OH)D is a better measure of vitamin D status with respect of BMD and mineral metabolism in patients of nephrotic syndrome.</p>
spellingShingle Aggarwal, A
Yadav, A
Ramachandran, R
Kumar, V
Kumar, V
Sachdeva, N
Khandelwal, N
Jha, V
Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome
title Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome
title_full Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome
title_fullStr Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome
title_full_unstemmed Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome
title_short Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome
title_sort bioavailable vitamin d levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome
work_keys_str_mv AT aggarwala bioavailablevitamindlevelsarereducedandcorrelatewithbonemineraldensityandmarkersofmineralmetabolisminadultswithnephroticsyndrome
AT yadava bioavailablevitamindlevelsarereducedandcorrelatewithbonemineraldensityandmarkersofmineralmetabolisminadultswithnephroticsyndrome
AT ramachandranr bioavailablevitamindlevelsarereducedandcorrelatewithbonemineraldensityandmarkersofmineralmetabolisminadultswithnephroticsyndrome
AT kumarv bioavailablevitamindlevelsarereducedandcorrelatewithbonemineraldensityandmarkersofmineralmetabolisminadultswithnephroticsyndrome
AT kumarv bioavailablevitamindlevelsarereducedandcorrelatewithbonemineraldensityandmarkersofmineralmetabolisminadultswithnephroticsyndrome
AT sachdevan bioavailablevitamindlevelsarereducedandcorrelatewithbonemineraldensityandmarkersofmineralmetabolisminadultswithnephroticsyndrome
AT khandelwaln bioavailablevitamindlevelsarereducedandcorrelatewithbonemineraldensityandmarkersofmineralmetabolisminadultswithnephroticsyndrome
AT jhav bioavailablevitamindlevelsarereducedandcorrelatewithbonemineraldensityandmarkersofmineralmetabolisminadultswithnephroticsyndrome